Medical technology is advancing the understanding and treatment of many diseases, but not all patients have full access to technological connections.
For example, children with type 1 diabetes living living outside urban areas may not receive the benefits of continuous glucose monitoring. This is according to a recent study by
Karishma Datye, MD, a pediatric endocrinologist at Vanderbilt University Medical Center, whose work highlights rurality as a key factor driving CGM-use discrepancies.
"It is critical for T1D providers to understand barriers to CGM use," Datye said. "Our study found that youth with T1D living in rural areas experience significant disparities in accessing care."
Follow us on X 